Providers

Provider Resource Center

Research

Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)

This pilot study focuses on assessing the suitability and potential effectiveness of ketamine, a glutamate modulator, as a rapid treatment option for obsessive-compulsive disorder (OCD) symptoms in adolescents and young adults. Targeting a specific group of 6 individuals aged 14 to 22 with clinically significant OCD, the study seeks participants who have not responded adequately to at least one Serotonin Reuptake Inhibitor (SRI) medication and a course of Cognitive-Behavioral Therapy (CBT), unless these treatments were inaccessible or intolerable. Each participant will undergo a single session of intravenous ketamine infusion, followed by regular assessments over a 14-day period to monitor the treatment's efficacy. After this initial treatment phase, all participants will be offered a three-month open treatment program for OCD, which may include medication, CBT, or a combination of both. This approach aims to explore ketamine's role as a fast-acting therapeutic alternative for young individuals grappling with OCD, especially those who have found limited relief from conventional treatments.

Financial Services

Manage your account or make a payment.

Disclaimers

Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules

Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.

© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy | HIPAA Policy

Providers

Provider Resource Center

Research

Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)

This pilot study focuses on assessing the suitability and potential effectiveness of ketamine, a glutamate modulator, as a rapid treatment option for obsessive-compulsive disorder (OCD) symptoms in adolescents and young adults. Targeting a specific group of 6 individuals aged 14 to 22 with clinically significant OCD, the study seeks participants who have not responded adequately to at least one Serotonin Reuptake Inhibitor (SRI) medication and a course of Cognitive-Behavioral Therapy (CBT), unless these treatments were inaccessible or intolerable. Each participant will undergo a single session of intravenous ketamine infusion, followed by regular assessments over a 14-day period to monitor the treatment's efficacy. After this initial treatment phase, all participants will be offered a three-month open treatment program for OCD, which may include medication, CBT, or a combination of both. This approach aims to explore ketamine's role as a fast-acting therapeutic alternative for young individuals grappling with OCD, especially those who have found limited relief from conventional treatments.

Disclaimers

Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules

Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.

© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy | HIPAA Policy